Serial circulating tumor DNA (ctDNA) monitoring in early-stage, HR+/HER2-, invasive lobular carcinoma (ILC) of the breast and impact on clin

Foldi J, Rivero-Hinojosa S, Satta S, et al. ASCO Annual Meeting 2025, Chicago, IL. May 30 - June 3, 2025.